EA201170164A1 - 9-замещенные-в-карбоксиоксадиазинохинолиновые производные, их получение и их применение в качестве антибактериальных средств - Google Patents
9-замещенные-в-карбоксиоксадиазинохинолиновые производные, их получение и их применение в качестве антибактериальных средствInfo
- Publication number
- EA201170164A1 EA201170164A1 EA201170164A EA201170164A EA201170164A1 EA 201170164 A1 EA201170164 A1 EA 201170164A1 EA 201170164 A EA201170164 A EA 201170164A EA 201170164 A EA201170164 A EA 201170164A EA 201170164 A1 EA201170164 A1 EA 201170164A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- carboxyoxadiazinohinoline
- derivatives
- substituted
- obtaining
- antibacterial means
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Объектом изобретения являются соединения формулы (I)в которой R, R, R, R', R', R', R, Rи Rявляются такими, как они описаны в заявке, в форме энантиомеров или смесей, а также их солей с кислотами и основаниями, их получение и их применение в качестве антибактериальных средств как в медицине, так и в ветеринарии.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08290678A EP2145891A1 (en) | 2008-07-09 | 2008-07-09 | 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
US9841308P | 2008-09-19 | 2008-09-19 | |
PCT/IB2009/006110 WO2010004394A1 (en) | 2008-07-09 | 2009-06-30 | 9-substituted-b-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201170164A1 true EA201170164A1 (ru) | 2011-12-30 |
Family
ID=40011090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201170164A EA201170164A1 (ru) | 2008-07-09 | 2009-06-30 | 9-замещенные-в-карбоксиоксадиазинохинолиновые производные, их получение и их применение в качестве антибактериальных средств |
Country Status (26)
Country | Link |
---|---|
US (1) | US8071590B2 (ru) |
EP (2) | EP2145891A1 (ru) |
JP (1) | JP2011527336A (ru) |
KR (1) | KR20110038071A (ru) |
CN (1) | CN102089313A (ru) |
AR (1) | AR072208A1 (ru) |
AT (1) | ATE541849T1 (ru) |
AU (1) | AU2009269735A1 (ru) |
BR (1) | BRPI0910786A2 (ru) |
CA (1) | CA2727820A1 (ru) |
CL (1) | CL2011000041A1 (ru) |
CO (1) | CO6331342A2 (ru) |
CY (1) | CY1112729T1 (ru) |
DK (1) | DK2310395T3 (ru) |
EA (1) | EA201170164A1 (ru) |
ES (1) | ES2380906T3 (ru) |
HK (1) | HK1151521A1 (ru) |
HR (1) | HRP20120329T1 (ru) |
IL (1) | IL210013A0 (ru) |
MX (1) | MX2011000313A (ru) |
NZ (1) | NZ590367A (ru) |
PL (1) | PL2310395T3 (ru) |
PT (1) | PT2310395E (ru) |
SI (1) | SI2310395T1 (ru) |
TW (1) | TW201002717A (ru) |
WO (1) | WO2010004394A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8669255B2 (en) * | 2011-09-29 | 2014-03-11 | Abbvie Inc. | Substituted octahydropyrrolo[1,2-a]pyrazines as calcium channel blockers |
CN112672997A (zh) * | 2018-07-19 | 2021-04-16 | 大日本住友制药株式会社 | 哒嗪酮衍生物 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CS274601B2 (en) * | 1983-07-27 | 1991-09-15 | Dainippon Pharmaceutical Co | Method of 1,8-naphthyridine derivative production |
DE3788177D1 (de) * | 1986-09-12 | 1993-12-23 | Hoffmann La Roche | Pyrido [3,2,1-ij]-1,3,4-benzoxadiazinderivate, Verfahren zu deren Herstellung, entsprechende pharmazeutische Präparate und im Verfahren verwendbare Zwischenprodukte. |
ZW16387A1 (en) * | 1986-09-12 | 1988-05-25 | Hoffmann La Roche | Tricyclic compounds |
JP2844079B2 (ja) * | 1988-05-23 | 1999-01-06 | 塩野義製薬株式会社 | ピリドンカルボン酸系抗菌剤 |
DE3906365A1 (de) | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
AU5449590A (en) | 1989-04-28 | 1990-11-29 | Daiichi Pharmaceutical Co., Ltd. | Anti-hiv drug |
HU205717B (en) | 1989-04-28 | 1992-06-29 | Daiichi Seiyaku Co | Process for producing pharmaceutical composition against human immunodeficiency, comprising pyridionecarboxylic acid derivative |
DE4234078A1 (de) | 1992-10-09 | 1994-04-14 | Bayer Ag | Chinoloncarbonsäuren |
US5646163A (en) * | 1992-10-30 | 1997-07-08 | The Procter & Gamble Company | Quinolone 5-(N-heterosubstituted amino) antimicrobials |
US5354747A (en) * | 1993-06-16 | 1994-10-11 | G. D. Searle & Co. | 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use |
DE4329600A1 (de) * | 1993-09-02 | 1995-03-09 | Bayer Ag | Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate |
DE4416622A1 (de) * | 1994-05-11 | 1995-11-16 | Bayer Ag | 8-Amino-10-(azabicycloalkyl)-pyrido[1,2,3-d.e] [1,3,4]benzoxa-diazinderivate |
EP0688772B1 (en) | 1994-06-16 | 1999-05-06 | LG Chemical Limited | Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituents and processes for their preparation |
US5576314A (en) * | 1994-12-12 | 1996-11-19 | Allelix Biopharmaceuticals Inc. | Bicyclic nonane and decane compounds having dopamine receptor affinity |
GB9601356D0 (en) | 1996-01-24 | 1996-03-27 | Pfizer | Novel compound |
JPH09323932A (ja) * | 1996-01-31 | 1997-12-16 | Sankyo Co Ltd | エイズ治療剤又は予防剤 |
EP0982030A3 (en) * | 1998-08-17 | 2000-05-10 | Pfizer Products Inc. | 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands |
CN1258531C (zh) | 1999-03-10 | 2006-06-07 | 第一制药株式会社 | 芳香族取代基取代的氨基甲基吡咯烷衍生物 |
CA2463794A1 (en) * | 2001-11-29 | 2003-06-12 | Merck & Co., Inc. | Cyclopropyl hexane containing oxazolidinone antibiotics and derivatives thereof |
SE0202133D0 (sv) | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Novel compounds |
DK1525200T3 (da) * | 2002-08-02 | 2007-12-03 | Ab Science | 2-(3-aminoaryl)amino-4-aryl-thiazoler til sygdomsbehandling |
WO2004096221A1 (en) * | 2003-04-30 | 2004-11-11 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
CA2538420A1 (en) | 2003-09-12 | 2005-03-24 | Warner-Lambert Company Llc | Quinolone antibacterial agents |
CA2542909C (en) * | 2003-10-23 | 2012-07-10 | Ab Science | 2-aminoaryloxazole compounds as tyrosine kinase inhibitors |
US20080039466A1 (en) * | 2004-01-30 | 2008-02-14 | Ab Science | 2-(3-Substituted-Aryl) Amino-4-Aryl-Thiazoles As Tyrosine Kinase Inhibitors |
WO2006027694A1 (en) | 2004-09-07 | 2006-03-16 | Pfizer Inc. | Inhibitors of the hiv integrase enzyme |
CA2584422A1 (en) | 2004-10-18 | 2006-04-27 | Eli Lilly And Company | 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
PT1838718E (pt) | 2005-01-10 | 2011-08-17 | Pfizer | Pirrolopirazoles, inibidores potentes da quinase |
WO2007011284A1 (en) | 2005-07-15 | 2007-01-25 | Astrazeneca Ab | Therapeutic agents |
NZ566208A (en) | 2005-08-11 | 2010-09-30 | Vertex Pharma | 2-Thiazolamide derivatives as modulators of cystic fibrosis transmembrane conductance regulators |
KR101292348B1 (ko) | 2005-09-09 | 2013-09-09 | 네르 쎄라퓨틱스 리미티드 | 피리딘 유도체 및 그의 정신병적 장애의 치료에 있어서의용도 |
FR2896416B1 (fr) * | 2006-01-24 | 2010-08-13 | Vetoquinol | Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine |
FR2928150A1 (fr) * | 2008-02-29 | 2009-09-04 | Vetoquinol Sa Sa | Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens |
-
2008
- 2008-07-09 EP EP08290678A patent/EP2145891A1/en not_active Withdrawn
-
2009
- 2009-06-02 TW TW098118150A patent/TW201002717A/zh unknown
- 2009-06-19 AR ARP090102249A patent/AR072208A1/es not_active Application Discontinuation
- 2009-06-23 US US12/489,528 patent/US8071590B2/en not_active Expired - Fee Related
- 2009-06-30 BR BRPI0910786A patent/BRPI0910786A2/pt not_active IP Right Cessation
- 2009-06-30 JP JP2011517257A patent/JP2011527336A/ja active Pending
- 2009-06-30 KR KR1020117002092A patent/KR20110038071A/ko not_active Application Discontinuation
- 2009-06-30 EP EP09794051A patent/EP2310395B1/en active Active
- 2009-06-30 AT AT09794051T patent/ATE541849T1/de active
- 2009-06-30 WO PCT/IB2009/006110 patent/WO2010004394A1/en active Application Filing
- 2009-06-30 MX MX2011000313A patent/MX2011000313A/es active IP Right Grant
- 2009-06-30 DK DK09794051.4T patent/DK2310395T3/da active
- 2009-06-30 ES ES09794051T patent/ES2380906T3/es active Active
- 2009-06-30 SI SI200930233T patent/SI2310395T1/sl unknown
- 2009-06-30 PT PT09794051T patent/PT2310395E/pt unknown
- 2009-06-30 CN CN2009801265488A patent/CN102089313A/zh active Pending
- 2009-06-30 NZ NZ590367A patent/NZ590367A/xx not_active IP Right Cessation
- 2009-06-30 CA CA2727820A patent/CA2727820A1/en not_active Abandoned
- 2009-06-30 EA EA201170164A patent/EA201170164A1/ru unknown
- 2009-06-30 PL PL09794051T patent/PL2310395T3/pl unknown
- 2009-06-30 AU AU2009269735A patent/AU2009269735A1/en not_active Abandoned
-
2010
- 2010-12-15 IL IL210013A patent/IL210013A0/en unknown
- 2010-12-30 CO CO10165119A patent/CO6331342A2/es active IP Right Grant
-
2011
- 2011-01-07 CL CL2011000041A patent/CL2011000041A1/es unknown
- 2011-05-31 HK HK11105454.5A patent/HK1151521A1/xx not_active IP Right Cessation
-
2012
- 2012-03-23 CY CY20121100306T patent/CY1112729T1/el unknown
- 2012-04-13 HR HRP20120329AT patent/HRP20120329T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
TW201002717A (en) | 2010-01-16 |
HRP20120329T1 (hr) | 2012-05-31 |
ATE541849T1 (de) | 2012-02-15 |
EP2310395B1 (en) | 2012-01-18 |
PT2310395E (pt) | 2012-04-26 |
IL210013A0 (en) | 2011-02-28 |
HK1151521A1 (ru) | 2012-02-03 |
US8071590B2 (en) | 2011-12-06 |
ES2380906T3 (es) | 2012-05-21 |
AR072208A1 (es) | 2010-08-11 |
SI2310395T1 (sl) | 2012-06-29 |
NZ590367A (en) | 2012-08-31 |
WO2010004394A1 (en) | 2010-01-14 |
AU2009269735A1 (en) | 2010-01-14 |
CL2011000041A1 (es) | 2011-07-15 |
EP2310395A1 (en) | 2011-04-20 |
BRPI0910786A2 (pt) | 2017-05-16 |
KR20110038071A (ko) | 2011-04-13 |
PL2310395T3 (pl) | 2012-09-28 |
DK2310395T3 (da) | 2012-04-16 |
CA2727820A1 (en) | 2010-01-14 |
CY1112729T1 (el) | 2016-02-10 |
US20100009980A1 (en) | 2010-01-14 |
EP2145891A1 (en) | 2010-01-20 |
CN102089313A (zh) | 2011-06-08 |
CO6331342A2 (es) | 2011-10-20 |
JP2011527336A (ja) | 2011-10-27 |
MX2011000313A (es) | 2011-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1118973T1 (el) | Παραγωγα αμιδιου βενζοϊμιδαζολο-καρβοξυλικου οξεος για τη θεραπεια μεταβολικων ή καρδιαγγειακων νοσηματων | |
EA201071264A1 (ru) | Аминодигидротиазиновые производные в качестве ингибиторов bace для лечения болезни альцгеймера | |
CY1116150T1 (el) | Παραγωγα οξαδιαζολης και η χρηση τους ως ενισχυτων μεταβοτροπικου υποδοχεα γλουταμικου - 842 | |
CY1120081T1 (el) | Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90 | |
EA201490647A1 (ru) | Производные бензотиазол-6-илуксусной кислоты и их применение для лечения вич-инфекции | |
EA201001680A1 (ru) | Соединения бензолсульфонамидтиазола и оксазола | |
EA201792421A1 (ru) | Амидозамещенные производные циклогексана | |
ECSP109953A (es) | Derivados de piridazinona | |
CY1116118T1 (el) | Κρυσταλλικες μορφες (r)-5-[3-χλωρο-4-(2,3-διυδροξυ-προποξυ)-βενζ[ζ]υλιδενιο]-2-([ζ]-προπυλιμινο)-3-o-τομυλ-θειαζολιδιν-4-ονης | |
EA201170772A1 (ru) | Органические соединения | |
EA201200318A1 (ru) | Гетероциклические оксимы | |
EA201001532A1 (ru) | Соединения фенилзамещенного 2-имино-3-метилпирролопиримидинона в качестве ингибиторов bace-1, композиции и их применение | |
CU20100062A7 (es) | Derivados de pirrolo [2,3-d] pirimidina como inhibidores de proteínas quinasas b | |
EA201070597A1 (ru) | Антибактериальные аналоги аминогликозида | |
EA200802210A1 (ru) | Замещенные пролинамиды, их получение и их применение в качестве лекарственных средств | |
EA201391720A1 (ru) | Замещенные диоксопиперидинилфталимидные производные | |
EA201001368A1 (ru) | Гетероциклические производные мочевины и способы их применения-211 | |
EA201071329A1 (ru) | Диамидные производные адамантана и их применение | |
EA201390772A1 (ru) | Новые соли и полиморфные формы афатиниба | |
EA201390908A1 (ru) | Производные бицикло[3.2.1]октиламида и их применение | |
CR11145A (es) | Pirazol amidas de acidos carboxilico utiles como microbicidas | |
ECSP078058A (es) | Nuevas glicinamidas sustituidas, su preparación y su uso como medicamentos | |
RU2010129238A (ru) | Применение производных изотиоцианата в качестве противомиеломных средств | |
CY1114140T1 (el) | Ενωσεις 4-πυριδινονης και η χρηση αυτων για τον καρκινο | |
EA200702253A1 (ru) | Фармацевтическая композиция |